Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,035 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pleiotropic effects of sitagliptin in the treatment of type 2 diabetes mellitus patients.
Kubota A, Maeda H, Kanamori A, Matoba K, Jin Y, Minagawa F, Obana M, Iemitsu K, Ito S, Amemiya H, Kaneshiro M, Takai M, Kaneshige H, Hoshino K, Ishikawa M, Minami N, Takuma T, Sasai N, Aoyagi S, Kawata T, Mokubo A, Takeda H, Honda S, Machimura H, Motomiya T, Waseda M, Naka Y, Tanaka Y, Terauchi Y, Matsuba I. Kubota A, et al. Among authors: maeda h. J Clin Med Res. 2012 Oct;4(5):309-13. doi: 10.4021/jocmr1061w. Epub 2012 Sep 12. J Clin Med Res. 2012. PMID: 23024732 Free PMC article.
Safety and efficacy of adding sitagliptin to insulin in patients with type 2 diabetes: the ASSIST-K study.
Takai M, Ishikawa M, Maeda H, Kanamori A, Kubota A, Amemiya H, Iizuka T, Iemitsu K, Iwasaki T, Uehara G, Umezawa S, Obana M, Kaneshige H, Kaneshiro M, Kawata T, Sasai N, Saito T, Takuma T, Takeda H, Tanaka K, Tsurui N, Nakajima S, Hoshino K, Honda S, Machimura H, Matoba K, Minagawa F, Minami N, Miyairi Y, Mokubo A, Motomiya T, Waseda M, Miyakawa M, Naka Y, Terauchi Y, Tanaka Y, Matsuba I. Takai M, et al. Among authors: maeda h. Diabetes Res Clin Pract. 2014 Mar;103(3):e30-3. doi: 10.1016/j.diabres.2013.12.045. Epub 2014 Jan 6. Diabetes Res Clin Pract. 2014. PMID: 24525293
Both glimepiride and high-dose metformin are important for sustained glucose lowering in Japanese type 2 diabetes patients on glimepiride-sitagliptin-metformin therapy: subanalysis of a single-center, open-label, randomized study.
Arai K, Maeda H, Shirabe S, Yamamoto R, Kumakura A, Yamauchi M, Hirao T, Hirao S, Hirao K. Arai K, et al. Among authors: maeda h. Diabetes Technol Ther. 2014 Jul;16(7):442-6. doi: 10.1089/dia.2013.0310. Epub 2014 Feb 14. Diabetes Technol Ther. 2014. PMID: 24528246 Clinical Trial.
Is a switch from insulin therapy to liraglutide possible in Japanese type 2 diabetes mellitus patients?
Kawata T, Kanamori A, Kubota A, Maeda H, Amamiya H, Takai M, Kaneshige H, Minagawa F, Iemitsu K, Kaneshiro M, Ishikawa M, Takeda H, Takuma T, Mokubo A, Machimura H, Obana M, Miyakawa M, Naka Y, Suzuki D, Terauchi Y, Toyoda M, Tanaka Y, Matsuba I. Kawata T, et al. Among authors: maeda h. J Clin Med Res. 2014 Apr;6(2):138-44. doi: 10.14740/jocmr1719w. Epub 2014 Feb 6. J Clin Med Res. 2014. PMID: 24578756 Free PMC article.
Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients.
Kubota A, Maeda H, Kanamori A, Matoba K, Jin Y, Minagawa F, Obana M, Iemitsu K, Ito S, Amamiya H, Kaneshiro M, Takai M, Kaneshige H, Hoshino K, Ishikawa M, Minami N, Takuma T, Sasai N, Aoyagi S, Kawata T, Mokubo A, Takeda H, Honda S, Machimura H, Motomiya T, Waseda M, Naka Y, Tanaka Y, Terauchi Y, Matsuba I. Kubota A, et al. Among authors: maeda h. J Diabetes Investig. 2012 Dec 20;3(6):503-9. doi: 10.1111/j.2040-1124.2012.00221.x. J Diabetes Investig. 2012. PMID: 24843615 Free PMC article.
4,035 results